第69回日本アレルギー学会学術大会

セッション情報

Poster Session

Dermatology

[PE27] Poster Session 27
Other skin diseases 2

Natalhie Acuña-Ortega, Maria C Zarate-Hernández, Sandra N González-Díaz, Cindy E De Lira-Quezada, Ligia L Carrasco-Díaz, Rodrigo A De la Cruz-Cruz (Regional Center of Allergy and Clinical Immunology, University Hospital “Dr José Eleuterio González”, Mexico)

Kazuo Takahashi1, Zenro Ikezawa2, Junichi Iwata3, Chie Miyabe1, Takaharu Ikeda1, Tamihiro Kawakami1 (1.Division of Dermatology, Tohoku Medical and Pharmaceutical University, Japan, 2.Ai Dermatology & Allergology Clinic, Japan, 3.Department of Dermatology, Atami Hospital, International University of Health and Welfare, Japan)

Sayaka Kuwatsuka1, Yutaka Kuwatsuka1, Saori Tomimura1, Motoi Takenaka1, Yoko Terasaka2, Koichi Izumikawa2, Yoshitomo Morinaga3,4, Katsunori Yanagihara3, Hiroyuki Murota1 (1.Department of Dermatology, Nagasaki University Hospital, Japan, 2.Infection Control and Education Center, Nagasaki University Hospital, Japan, 3.Department of Laboratory Medicine, Nagasaki University Hospital, Japan, 4.Department of Microbiology, Faculty of Medicine, University of Toyama, Japan)

Neil Inhaber1, Marc A Riedl2, Paula J Busse3, Raffi Tachdjian4, Daniel Soteres5, James Hao6, Peng Lu6, Aleena Banerji7 (1.Takeda Pharmaceutical Company Limited, USA, 2.Division of Rheumatology, Allergy & Immunology, University of California San Diego, USA, 3.Division of Allergy and Clinical Immunology, Icahn School of Medicine at Mount Sinai, USA, 4.AIRE Medical of Los Angeles, University of California Los Angeles, USA, 5.Asthma and Allergy Associates PC, USA, 6.Shire, a Takeda company, USA, 7.Massachusetts General Hospital, Harvard Medical School, USA)

Misato Maeno1, Risa Tamagawa-Mineoka1, Yukiyasu Arakawa1, Koji Masuda1, Tetsuya Adachi2, Norito Katoh1 (1.Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan, 2.Department of Dental Medicine, Kyoto Prefectural University of Medicine, Japan)

Marcus Maurer1, Hilary Longhurst2,3, Werner Aberer4, Laurence Bouillet5, Anete Grumach6, Jaco Botha7, Irmgard Andresen7, Giorgio Giannattasio7, Teresa Caballero8 (1.Charité Universitätsmedizin Berlin, Germany, 2.Addenbrooke's Hospital, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, UK, 3.University College London Hospitals, UK, 4.Medical University of Graz, Austria, 5.National Reference Centre for Angioedema, Grenoble University, France, 6.University Center Health ABC, Brazil, 7.Shire (Takeda Pharmaceutical Company Limited.), Switzerland, 8.Hospital Universitario La Paz, Biomedical Research Network on Rare Diseases (CIBERER, U754), Spain)

Jane Hsieh1, Jacquie Badiou2, Rozita Borici-Mazi3, Teresa Caballero4, Amin Kanani5, Gina Lacuesta6, Christine McCusker7, Susan Waserman8, Stephen Betschel9 (1.Department of Medicine, University of Toronto, Canada, 2.Hereditary Angioedema (HAE), Canada, 3.Department of Medicine, Queen's University, Canada, 4.Hospital Universitario La Paz, Spain, 5.Department of Medicine, University of British Columbia, Canada, 6.Department of Medicine, Dalhousie University, Canada, 7.Department of Immunology, McGill University Health Centre, Canada, 8.Department of Medicine, McMaster University, Canada, 9.Department of Medicine, University of Toronto, Canada)

Jane Hsieh1, Jacquie Badiou2, Rozita Borici-Mazi3, Teresa Caballero4, Amin Kanani5, Gina Lacuesta6, Christine McCusker7, Susan Waserman8, Stephen Betschel9 (1.Department of Medicine, University of Toronto, Canada, 2.Hereditary Angioedema (HAE), Canada, 3.Department of Medicine, Queen's University, Canada, 4.Hospital Universitario La Paz, Spain, 5.Department of Medicine, University of British Columbia, Canada, 6.Department of Medicine, Dalhousie University, Canada, 7.Department of Immunology, McGill University Health Centre, Canada, 8.Department of Medicine, McMaster University, Canada, 9.Department of Medicine, University of Toronto, Canada)